Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows

[ad_1]

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults. SIGRID GOMBERT/SCIENCE …

Sources

1/ https://Google.com/

2/ https://fortune.com/well/article/personalized-kidney-cancer-vaccine-neovax-dana-farber-clinical-trial/

The mention sources can contact us to remove/changing this article

[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts

Increase of pertussis cases in the EU/EEA

[ad_1] Epidemiological situation Pertussis is an endemic disease in the EU/EEA and worldwide. Every three to five years, larger epidemics are expected even with high vaccination coverge. After a few years of limited circulation in the…